LOS ANGELES CAPITAL MANAGEMENT LLC - VANDA PHARMACEUTICALS INC ownership

VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 180 filers reported holding VANDA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 3.16 and the average weighting 0.0%.

Quarter-by-quarter ownership
LOS ANGELES CAPITAL MANAGEMENT LLC ownership history of VANDA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$2,012,921
-6.8%
465,954
+42.2%
0.01%0.0%
Q2 2023$2,159,345
+33.6%
327,670
+37.6%
0.01%
+28.6%
Q1 2023$1,616,869
+220.1%
238,125
+248.4%
0.01%
+250.0%
Q4 2022$505,158
-26.8%
68,357
-2.2%
0.00%
-50.0%
Q3 2022$690,000
-11.9%
69,876
-2.8%
0.00%0.0%
Q2 2022$783,000
-16.0%
71,876
-12.8%
0.00%0.0%
Q1 2022$932,000
-27.9%
82,3950.0%0.00%
-20.0%
Q4 2021$1,293,000
-8.4%
82,395
+0.0%
0.01%
-16.7%
Q3 2021$1,412,000
+21.7%
82,370
+52.7%
0.01%
+20.0%
Q2 2021$1,160,000
+27.3%
53,949
-11.1%
0.01%
+25.0%
Q1 2021$911,000
-24.2%
60,679
-33.7%
0.00%
-20.0%
Q4 2020$1,202,000
+34.2%
91,478
-1.3%
0.01%
+25.0%
Q3 2020$896,000
-47.9%
92,703
-38.3%
0.00%
-50.0%
Q2 2020$1,720,000
-21.6%
150,364
-29.0%
0.01%
-42.9%
Q1 2020$2,193,000
-51.3%
211,632
-22.8%
0.01%
-36.4%
Q4 2019$4,501,000
+45.2%
274,274
+17.5%
0.02%
+29.4%
Q3 2019$3,100,000
+520.0%
233,414
+558.2%
0.02%
+466.7%
Q2 2019$500,000
-27.0%
35,462
-4.7%
0.00%
-25.0%
Q1 2019$685,000
-68.2%
37,202
-54.8%
0.00%
-69.2%
Q4 2018$2,152,000
-0.6%
82,352
-12.7%
0.01%
+18.2%
Q3 2018$2,165,000
+201.1%
94,342
+150.1%
0.01%
+175.0%
Q2 2018$719,000
+13.1%
37,7220.0%0.00%0.0%
Q1 2018$636,000
+11.4%
37,722
+0.3%
0.00%
+33.3%
Q4 2017$571,000
+106.1%
37,597
+142.7%
0.00%
+50.0%
Q3 2017$277,000
-18.5%
15,492
-63.2%
0.00%
-60.0%
Q2 2013$340,00042,0580.01%
Other shareholders
VANDA PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Profit Investment Management, LLC 326,997$1,412,6271.00%
Stonepine Capital Management, LLC 477,903$2,064,5410.69%
Krensavage Asset Management, LLC 360,429$1,5570.57%
Nantahala Capital Management 1,000,000$4,320,0000.37%
Monaco Asset Management SAM 135,000$583,2000.17%
CTC Alternative Strategies, Ltd. 18,400$79,4880.15%
GSA CAPITAL PARTNERS LLP 406,019$1,7540.15%
Sio Capital Management, LLC 97,616$421,7010.13%
HUSSMAN STRATEGIC ADVISORS, INC. 156,000$673,9200.13%
Virtus ETF Advisers LLC 48,530$209,6500.13%
View complete list of VANDA PHARMACEUTICALS INC shareholders